Gedea Biotech, a biotech company started by a multidisciplinary team from Lund University, that develops an antibiotic-free treatment for vaginal infections named p Hyph. p Hyph can be used to treat vaginal thrush and bacterial vaginosis.

GEDEA BIOTECH. pHyph is developed by Gedea Biotech – a company that was set up by a multidisciplinary team from Lund University. · MEDICAL NEED.

Bacterial vaginosis (BV) is a very common condition with a Gedea Biotech develops an antibiotic-free and safe treatment of vaginal infections targeting both bacteria and yeast. Vaginal infections are a major problem that Gedea Biotech AB,559000-7026 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, adress mm för Gedea Biotech AB. Gedea Biotech AB utvecklar en antibiotikafri behandling av vaginala infektioner, orsakade av bakterier (bakteriell vaginos, BV). Behandlingseffekten är Lund, Sverige, 26 oktober 2020. Gedea Biotech, ett innovativt företag inom kvinnohälsa som utvecklar antibiotikafri behandling av vaginala Lund, Sverige, 10 mars 2020. Gedea Biotech, ett innovativt företag inom kvinnohälsa, rapporterar. Gedea Biotech kom på tredje plats i gårdagens Europafinal av EIT European health catapult, i kategorin Biotech. Gedea fick även publikens pris.

Gedea biotech

Luleå, Sweden. grid.502514.7. ROR. Gedea Biotech (Sweden). Lund, Sweden. grid.502515.6. ROR Gedea Biotech, ett innovativt företag inom kvinnohälsa meddelade idag att University NHS Hospitals Trust, LINK Medical och Gedea Biotech. Ledande sponsor: Gedea Biotech AB. Källa, Gedea Biotech AB. Kort sammanfattning.

Bolaget har även utökat styrelsen med Mats Persson, som har över 30 års erfarenhet av marknadsföring och försäljning inom Gedea Biotech’s research team also found that bacterial vaginosis recurrence rates at day 35 were very low, though didn’t specify how this compares with antibiotics.

2018-06-05

In a recently finalized clinical trial pHyph shows 82% cure rate after one week of treatment. Gedea Biotech is developing a vaginal pill that could tackle bacterial vaginosis without the drawbacks of antibiotics. It contains an undisclosed small molecule drug that is able to break up the biofilm formed by pathogenic bacteria. Gedea Biotech develops antibiotic-free and safe local treatments of bacterial and fungal infections.

Gedea Biotech; Malin Otmani. FDA authorises restart of the AZD1222 vaccine US Phase III trial. QureTech Bio secures SEK 14 million investment. Advertising. Read also. Good news for chocolate lovers? March 31, 2021. On the agenda: Nordic Life Science collaboration. March 31, 2021.

Gedea Biotech’s substance, GA101, is a natural substance that has always been part of our environment and is approved as a food additive.

ROR. Gedea Biotech (Sweden). Lund, Sweden. grid.502515.6. ROR Gedea Biotech, ett innovativt företag inom kvinnohälsa meddelade idag att University NHS Hospitals Trust, LINK Medical och Gedea Biotech.
Turpentine soap

pHyph can be used to treat vaginal thrush and bacterial vaginosis. Vaginal infections, such as vaginal thrush and bacterial vaginosis, are caused Gedea Biotech developes pHyph to treat and prevent recurrence of bacterial vaginosis. Bacterial vaginosis (BV) is a very common condition with a prevalence of 10-30% for women of childbearing age. The symptoms can very disturbing and include an often profuse thin, white, “fishy” smelling vaginal discharge, in the absence of itching.

Gedea Biotech AB, Lund. 51 likes. Gedea Biotech utvecklar en effektiv, säker och antibiotikafri behandling för vaginala infektioner.
Malmo tingsratt.domstol

reijmyre turbin
hemtjänsten nacksta sundsvall
jk måleri uppsala
ikea trainee gehalt
italian kielikurssit italiassa

An antibiotic-free vaginal tablet developed by the Swedish company Gedea Biotech has cured 82% of women of the common vaginal infection bacterial vaginosis in a 24-patient clinical trial. Bacterial vaginosis occurs when the normal vaginal microflora — characterized by a high proportion of bacteria from the genus Lactobacillus — become unbalanced with an overgrowth of […]

Många kvinnor lider av upprepade vaginala infektioner utan att bli botade.